Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 2, 2003 - Issue 3
Submit an article Journal homepage
58
Views
3
CrossRef citations to date
0
Altmetric
Review

Anticipating and treating opioidassociated adverse effects

Christopher M Herndon Scientific Liaison – Neurosciences, Division of Clinical Affairs, Ortho-McNeil Pharmaceutical. Clinical Assistant Professor, Texas Tech University School of Pharmacy, 1301 Engle Court, O’Fallon, IL 62269, USA. [email protected]
,
Donna AK Kalauokalani Assistant Professor, Departments of Anesthesiology, Psychiatry and Internal Medicine, School of Medicine, Washington University in St Louis, 660 S. Euclid Avenue, Box 8054, St Louis, MO 63110, USA. [email protected]
,
Amy J Cunningham Clinical Pharmacist, Don & Sybil Harrington Cancer Center, Clinical Assistant Professor, Texas Tech University School of Pharmacy, 1500 Wallace Blvd, Amarillo, TX 79106, USA. [email protected]
,
Kenneth C Jackson II Assistant Professor, International Pain Institute, Texas Tech University Health Sciences Center School of Pharmacy, Room 1C162, 3601 4th Street Stop 8162, Lubbock, TX 79430-8162, USA. [email protected]
&
Edwin D Dunteman Director, A&A Pain Institute, Clinical Assistant Professor, University of Missouri-Columbia, 456 N. New Ballas, Suite 154, St Louis, MO 63141, USA. [email protected]
Pages 305-319 | Published online: 03 Mar 2005

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Diana I. Brixner, Gary M. Oderda, Carl L. Roland & Dale A. Rublee. (2006) Opioid Expenditures and Utilization in the Medicaid System. Journal of Pain & Palliative Care Pharmacotherapy 20:1, pages 5-13.
Read now
Edwin D. Dunteman. (2005) Levetiracetam as an Adjunctive Analgesic in Neoplastic Plexopathies. Journal of Pain & Palliative Care Pharmacotherapy 19:1, pages 35-43.
Read now

Articles from other publishers (1)

Kuntheavy Ing Lorenzini & François Girardin. (2019) Direct‐acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV‐infected patients. Liver International 40:1, pages 32-44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.